Sex differences in cardiometabolic risk factors, pharmacological treatment and risk factor control in type 2 diabetes: findings from the Dutch Diabetes Pearl cohort.
Marit de JongMarieke J OskamSimone J S SepBehiye OzcanFemke RuttersEric J G SijbrandsPetra J M EldersSarah E SiegelaarJ Hans DeVriesCees J TackMarielle SchroijenHarold W de ValkEvertine J AbbinkCoen D A StehouwerIngrid JazetBruce H R WolffenbuttelSanne A E PetersMiranda T Schramnull nullPublished in: BMJ open diabetes research & care (2021)
In this Dutch T2D population, women had a slightly different cardiometabolic risk profile compared with men and a substantially higher BMI. Women had a higher probability of being treated with antihypertensive medication in the presence of high CVD risk and elevated SBP than men, and were less likely than men to achieve treatment targets for HbA1c and LDL levels.